- Understanding the key players in tumour immunology
- Getting up-to-date on the role of immunotherapy in advanced NSCLC
- The role of biomarkers in selecting NSCLC patients for IT
- Mechanism of combining angiogenesis inhibition with checkpoint inhibition
- Management of IT toxicity and use of IT in specific subgroups of patients
Download the programme
How to apply
Application is via online form. During the application process you will be required to upload your CV including a list of your publications.
Applications for the course are now closed.
Who can apply?
While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.
To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.
Successful applicants will benefit from complimentary course registration and accommodation.
In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to selected applicants as a contribution versus their travel costs. The reimbursement will be processed after the course against original invoices/vouchers. Please be aware that visa costs are NOT covered by the travel grant and are the participant's responsibility.
The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
John B. Haanen, Netherlands
Aurélien Marabelle, France
Venue and accommodation
Mövenpick Hotel Zürich Airport
Walter Mittelholzerstrasse 8